Optimizerx Corporation (OPRX)

$9.35

-0.18

(-1.89%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Optimizerx Corporation

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 13.00M → 28.36M (in $), with an average increase of 21.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -2.86M → -4.14M (in $), with an average decrease of 44.5% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 37.0% return, outperforming this stock by 70.9%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 12.5% return, outperforming this stock by 94.0%

Performance

  • $9.34
    $9.90
    $9.35
    downward going graph

    0.11%

    Downside

    Day's Volatility :5.61%

    Upside

    5.51%

    downward going graph
  • $6.92
    $16.65
    $9.35
    downward going graph

    25.99%

    Downside

    52 Weeks Volatility :58.44%

    Upside

    43.84%

    downward going graph

Returns

PeriodOptimizerx CorporationSector (Health Care)Index (Russel 2000)
3 Months
-37.63%
-0.7%
0.0%
6 Months
9.54%
6.6%
0.0%
1 Year
-33.91%
3.7%
-1.5%
3 Years
-81.06%
14.0%
-21.8%

Highlights

Market Capitalization
180.8M
Book Value
$6.97
Earnings Per Share (EPS)
-0.81
PEG Ratio
1.61
Wall Street Target Price
16.17
Profit Margin
-24.56%
Operating Margin TTM
-9.21%
Return On Assets TTM
-6.89%
Return On Equity TTM
-13.9%
Revenue TTM
71.5M
Revenue Per Share TTM
4.18
Quarterly Revenue Growth YOY
44.3%
Gross Profit TTM
39.0M
EBITDA
-15.1M
Diluted Eps TTM
-0.81
Quarterly Earnings Growth YOY
-0.67
EPS Estimate Current Year
0.31
EPS Estimate Next Year
0.32
EPS Estimate Current Quarter
0.02
EPS Estimate Next Quarter
0.14

Analyst Recommendation

Buy
    91%Buy
    8%Hold
    0
    0%Sell
Based on 12 Wall street analysts offering stock ratings for Optimizerx Corporation(by analysts ranked 0 to 5 stars)
Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
12
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 72.94%

Current $9.35
Target $16.17

Company Financials

FY18Y/Y Change
Revenue
21.2M
↑ 74.86%
Net Income
226.3K
↓ 110.76%
Net Profit Margin
1.07%
↑ 18.42%
FY19Y/Y Change
Revenue
24.6M
↑ 15.99%
Net Income
-3.1M
↓ 1488.41%
Net Profit Margin
-12.78%
↓ 13.85%
FY20Y/Y Change
Revenue
43.3M
↑ 76.08%
Net Income
-2.4M
↓ 24.15%
Net Profit Margin
-5.5%
↑ 7.28%
FY21Y/Y Change
Revenue
61.3M
↑ 41.51%
Net Income
273.9K
↓ 111.49%
Net Profit Margin
0.45%
↑ 5.95%
FY22Y/Y Change
Revenue
62.5M
↑ 1.89%
Net Income
-10.6M
↓ 3964.56%
Net Profit Margin
-16.95%
↓ 17.4%
FY23Y/Y Change
Revenue
71.5B
↑ 114425.74%
Net Income
-17.6B
↑ 165832.65%
Net Profit Margin
-24.56%
↓ 7.61%
Q3 FY22Q/Q Change
Revenue
15.1M
↑ 7.92%
Net Income
-3.2M
↓ 17.72%
Net Profit Margin
-21.06%
↑ 6.56%
Q4 FY22Q/Q Change
Revenue
19.7M
↑ 30.29%
Net Income
212.7K
↓ 106.69%
Net Profit Margin
1.08%
↑ 22.14%
Q1 FY23Q/Q Change
Revenue
13.0M
↓ 33.84%
Net Income
659.1M
↑ 309795.94%
Net Profit Margin
5.1K%
↑ 5067.59%
Q2 FY23Q/Q Change
Revenue
13.8M
↑ 6.27%
Net Income
-4.2M
↓ 100.63%
Net Profit Margin
-30.12%
↓ 5098.79%
Q3 FY23Q/Q Change
Revenue
16.3M
↑ 18.19%
Net Income
-2.9M
↓ 31.15%
Net Profit Margin
-17.54%
↑ 12.58%
Q4 FY23Q/Q Change
Revenue
28.4M
↑ 73.71%
Net Income
-4.1M
↑ 44.54%
Net Profit Margin
-14.6%
↑ 2.94%
FY18Y/Y Change
Total Assets
25.1M
↑ 156.61%
Total Liabilities
6.6M
↑ 86.16%
FY19Y/Y Change
Total Assets
56.6M
↑ 126.06%
Total Liabilities
11.8M
↑ 78.53%
FY20Y/Y Change
Total Assets
60.3M
↑ 6.51%
Total Liabilities
10.4M
↓ 12.08%
FY21Y/Y Change
Total Assets
141.0M
↑ 133.7%
Total Liabilities
9.6M
↓ 7.23%
FY22Y/Y Change
Total Assets
134.7M
↓ 4.49%
Total Liabilities
8.5M
↓ 11.09%
FY23Y/Y Change
Total Assets
183.4B
↑ 136084.39%
Total Liabilities
56.8B
↑ 665216.27%
Q3 FY22Q/Q Change
Total Assets
135.9M
↓ 7.85%
Total Liabilities
6.3M
↓ 4.97%
Q4 FY22Q/Q Change
Total Assets
134.7M
↓ 0.9%
Total Liabilities
8.5M
↑ 35.54%
Q1 FY23Q/Q Change
Total Assets
131.7M
↓ 2.2%
Total Liabilities
7.7M
↓ 9.5%
Q2 FY23Q/Q Change
Total Assets
121.3M
↓ 7.87%
Total Liabilities
5.5M
↓ 28.71%
Q3 FY23Q/Q Change
Total Assets
123.9M
↑ 2.15%
Total Liabilities
7.8M
↑ 41.98%
Q4 FY23Q/Q Change
Total Assets
183.4M
↑ 47.97%
Total Liabilities
56.8M
↑ 626.38%
FY18Y/Y Change
Operating Cash Flow
792.6K
↓ 153.56%
Investing Cash Flow
-5.7M
↑ 13362.19%
Financing Cash Flow
8.7M
↓ 2327.11%
FY19Y/Y Change
Operating Cash Flow
-1.7M
↓ 309.55%
Investing Cash Flow
-10.6M
↑ 86.08%
Financing Cash Flow
22.2M
↑ 155.38%
FY20Y/Y Change
Operating Cash Flow
-6.3M
↑ 279.96%
Investing Cash Flow
-124.7K
↓ 98.82%
Financing Cash Flow
-1.9M
↓ 108.57%
FY21Y/Y Change
Operating Cash Flow
726.0K
↓ 111.51%
Investing Cash Flow
-486.0K
↑ 289.66%
Financing Cash Flow
73.9M
↓ 3989.16%
FY22Y/Y Change
Operating Cash Flow
10.7M
↑ 1367.43%
Investing Cash Flow
-486.0K
↑ 0.0%
Financing Cash Flow
-19.0M
↓ 125.64%
Q3 FY22Q/Q Change
Operating Cash Flow
3.5M
↑ 1023.63%
Investing Cash Flow
-37.5M
↑ 1668.42%
Financing Cash Flow
-12.0M
↓ 4883.63%
Q4 FY22Q/Q Change
Operating Cash Flow
2.8M
↓ 19.03%
Investing Cash Flow
-18.5M
↓ 50.71%
Financing Cash Flow
-7.4M
↓ 38.11%
Q1 FY23Q/Q Change
Operating Cash Flow
-86.3K
↓ 103.08%
Investing Cash Flow
-1.5M
↓ 91.62%
Financing Cash Flow
-129.8K
↓ 98.26%
Q2 FY23Q/Q Change
Operating Cash Flow
-2.4M
↑ 2643.15%
Investing Cash Flow
3.2M
↓ 308.09%
Financing Cash Flow
-7.5M
↑ 5670.9%

Technicals Summary

Sell

Neutral

Buy

Optimizerx Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Optimizerx Corporation
Optimizerx Corporation
-21.95%
9.54%
-33.91%
-81.06%
-21.24%
Solventum Corp
Solventum Corp
-10.64%
-10.64%
-10.64%
-10.64%
-10.64%
Veeva Systems Inc.
Veeva Systems Inc.
-12.8%
-3.39%
8.83%
-26.33%
55.83%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-5.98%
30.6%
1.83%
40.83%
40.83%
Healthequity Inc
Healthequity Inc
-3.72%
6.22%
37.05%
12.91%
23.47%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Optimizerx Corporation
Optimizerx Corporation
NA
NA
1.61
0.31
-0.14
-0.07
NA
6.97
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
62.03
62.03
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
28.08
28.08
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
125.42
125.42
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Optimizerx Corporation
Optimizerx Corporation
Buy
$180.8M
-21.24%
NA
-24.56%
Solventum Corp
Solventum Corp
NA
$11.7B
-10.64%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.3B
55.83%
62.03
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.0B
40.83%
28.08
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
23.47%
125.42
5.57%

Institutional Holdings

  • First Light Asset Management, LLC

    9.52%

  • BlackRock Inc

    6.25%

  • Vanguard Group Inc

    5.62%

  • Divisadero Street Capital Management, LP

    5.23%

  • Awm Investment Company Inc

    4.52%

  • Blair William & Co

    4.08%

Corporate Announcements

  • Optimizerx Corporation Earnings

    Optimizerx Corporation’s price-to-earnings ratio stands at None

    Read More

Company Information

optimizerx partners with pharmaceutical companies to offer electronic versions of their patient savings and support materials within the eprescribing workflow of leading electronic health record platforms. using the samplemd technology, providers can more efficiently distribute savings and support materials to their patients. the ecoupon technology, available in the eprescribing workflow of over 300,000+ providers, has expanded the distribution of savings and support materials to millions of patients throughout the us and aims to increase adherence rates and affordability of prescribed medications. about optimizerx corp. optimizerx corp. provides unique consumer and physician platforms to help patients better afford and comply with their medications, while offering pharmaceutical companies effective ways to expand awareness, affordability and adherence to their brands. for more information on samplemd, please call us at (877) 568-3840 or visit www.samplemd.com.

Organization
Optimizerx Corporation
Employees
135
CEO
Mr. William J. Febbo
Industry
Technology Services

Discover More

FAQs